Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 6
2011 6
2012 9
2013 6
2014 4
2015 4
2016 1
2018 1
2019 2
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean lindsay v. Rhodes (1 results)?
Single Live Cell Imaging of Multidrug Resistance Using Silver Ultrasmall Nanoparticles as Biosensing Probes in Triple-Negative Breast Cancer Cells.
Alim E, Stone L, Sharma N, McMahon S, Allen Z, Aceto P, Victor P, Mitchell LF, Raulerson A, Schepke C, Grabowski J, Valera R, Kalia K, Fernandez M, Kouba K, Shannon M, Johnson V, Forestal C, Pongo I, Ospina S, Fontanez N, Rosenberg M, Levin M, Martinez D, Betancourt YP, Rhodes LV, Lee KJ. Alim E, et al. Among authors: rhodes lv. ACS Appl Bio Mater. 2023 Nov 20;6(11):4672-4681. doi: 10.1021/acsabm.3c00451. Epub 2023 Oct 16. ACS Appl Bio Mater. 2023. PMID: 37844294
Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells.
Matossian MD, Elliott S, Rhodes LV, Martin EC, Hoang VT, Burks HE, Zuercher WJ, Drewry DH, Collins-Burow BM, Burow ME. Matossian MD, et al. Among authors: rhodes lv. Oncol Lett. 2021 May;21(5):380. doi: 10.3892/ol.2021.12641. Epub 2021 Mar 16. Oncol Lett. 2021. PMID: 33777204 Free PMC article.
Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model.
Matossian MD, Burks HE, Elliott S, Hoang VT, Bowles AC, Sabol RA, Wahba B, Anbalagan M, Rowan B, Abazeed ME, Bunnell BA, Moroz K, Miele L, Rhodes LV, Jones SD, Martin EC, Collins-Burow BM, Burow ME. Matossian MD, et al. Among authors: rhodes lv. BMC Cancer. 2019 Mar 7;19(1):205. doi: 10.1186/s12885-019-5401-2. BMC Cancer. 2019. PMID: 30845999 Free PMC article.
A novel patient-derived xenograft model for claudin-low triple-negative breast cancer.
Matossian MD, Burks HE, Bowles AC, Elliott S, Hoang VT, Sabol RA, Pashos NC, O'Donnell B, Miller KS, Wahba BM, Bunnell BA, Moroz K, Zea AH, Jones SD, Ochoa AC, Al-Khami AA, Hossain F, Riker AI, Rhodes LV, Martin EC, Miele L, Burow ME, Collins-Burow BM. Matossian MD, et al. Among authors: rhodes lv. Breast Cancer Res Treat. 2018 Jun;169(2):381-390. doi: 10.1007/s10549-018-4685-2. Epub 2018 Feb 1. Breast Cancer Res Treat. 2018. PMID: 29392581 Free PMC article.
Glyceollin, a novel regulator of mTOR/p70S6 in estrogen receptor positive breast cancer.
Bratton MR, Martin EC, Elliott S, Rhodes LV, Collins-Burow BM, McLachlan JA, Wiese TE, Boue SM, Burow ME. Bratton MR, et al. Among authors: rhodes lv. J Steroid Biochem Mol Biol. 2015 Jun;150:17-23. doi: 10.1016/j.jsbmb.2014.12.014. Epub 2015 Mar 12. J Steroid Biochem Mol Biol. 2015. PMID: 25771071 Free PMC article.
37 results